MET, MET proto-oncogene, receptor tyrosine kinase, 4233
N. diseases: 594; N. variants: 47
Source: ALL
Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
7 | 116717990 | intron variant | A/G;T | snv |
|
0.800 | 1.000 | 2 | 2013 | 2017 | |||||||||||
|
7 | 116777427 | missense variant | A/G;T | snv |
|
Neoplasms | 0.700 | 1.000 | 1 | 2002 | 2002 | ||||||||||
|
7 | 116717314 | intron variant | A/G | snv | 0.26 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
7 | 116700032 | missense variant | A/G | snv | 1.6E-03 | 6.3E-03 |
|
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Otorhinolaryngologic Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
7 | 116798457 | downstream gene variant | G/T | snv | 0.64 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||||
|
7 | 116771971 | splice donor variant | GAGCTACTTTTCCAGAAGGTATATTTC/- | delins |
|
0.700 | 0 | ||||||||||||||
|
7 | 116771990 | splice donor variant | G/T | snv |
|
0.700 | 0 | ||||||||||||||
|
0.752 | 0.200 | 7 | 116771936 | missense variant | C/T | snv | 7.9E-03 | 9.0E-03 |
|
Neoplasms | 0.720 | 1.000 | 3 | 2003 | 2015 | ||||||
|
0.752 | 0.200 | 7 | 116771936 | missense variant | C/T | snv | 7.9E-03 | 9.0E-03 |
|
Neoplasms | 0.700 | 1.000 | 1 | 1975 | 1975 | ||||||
|
0.752 | 0.200 | 7 | 116771936 | missense variant | C/T | snv | 7.9E-03 | 9.0E-03 |
|
Neoplasms | 0.010 | < 0.001 | 1 | 2005 | 2005 | ||||||
|
0.752 | 0.200 | 7 | 116771936 | missense variant | C/T | snv | 7.9E-03 | 9.0E-03 |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2003 | 2003 | ||||||
|
0.752 | 0.200 | 7 | 116771936 | missense variant | C/T | snv | 7.9E-03 | 9.0E-03 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | < 0.001 | 1 | 2019 | 2019 | ||||||
|
0.752 | 0.200 | 7 | 116771936 | missense variant | C/T | snv | 7.9E-03 | 9.0E-03 |
|
0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.752 | 0.200 | 7 | 116771936 | missense variant | C/T | snv | 7.9E-03 | 9.0E-03 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||||
|
0.752 | 0.200 | 7 | 116771936 | missense variant | C/T | snv | 7.9E-03 | 9.0E-03 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2005 | 2005 | ||||||
|
0.752 | 0.200 | 7 | 116771936 | missense variant | C/T | snv | 7.9E-03 | 9.0E-03 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | < 0.001 | 1 | 2019 | 2019 | ||||||
|
0.752 | 0.200 | 7 | 116771936 | missense variant | C/T | snv | 7.9E-03 | 9.0E-03 |
|
0.010 | 1.000 | 1 | 2005 | 2005 | |||||||
|
0.752 | 0.200 | 7 | 116771936 | missense variant | C/T | snv | 7.9E-03 | 9.0E-03 |
|
0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.752 | 0.200 | 7 | 116771936 | missense variant | C/T | snv | 7.9E-03 | 9.0E-03 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||
|
0.752 | 0.200 | 7 | 116771936 | missense variant | C/T | snv | 7.9E-03 | 9.0E-03 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||
|
0.752 | 0.200 | 7 | 116771936 | missense variant | C/T | snv | 7.9E-03 | 9.0E-03 |
|
Neoplasms; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2005 | 2005 | ||||||
|
0.752 | 0.200 | 7 | 116771936 | missense variant | C/T | snv | 7.9E-03 | 9.0E-03 |
|
Neoplasms | 0.010 | < 0.001 | 1 | 2005 | 2005 | ||||||
|
0.752 | 0.200 | 7 | 116771936 | missense variant | C/T | snv | 7.9E-03 | 9.0E-03 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||
|
0.790 | 0.120 | 7 | 116700208 | missense variant | A/G | snv | 2.7E-02 | 1.8E-02 |
|
Neoplasms | 0.010 | < 0.001 | 1 | 2013 | 2013 | ||||||
|
0.790 | 0.120 | 7 | 116700208 | missense variant | A/G | snv | 2.7E-02 | 1.8E-02 |
|
Neoplasms; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 |